132
Views
7
CrossRef citations to date
0
Altmetric
Original Research

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients

, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2061-2070 | Published online: 31 Aug 2020

References

  • SinghD, AgustiA, AnzuetoA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-201930846476
  • VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
  • CrimC, CalverleyPM, AndersonJA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J. 2009;34(3):641–647. doi:10.1183/09031936.0019390819443528
  • KitaH. Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev. 2011;242(1):161–177. doi:10.1111/j.1600-065X.2011.01026.x21682744
  • BafadhelM, PetersonS, De BlasMA, et al. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. Lancet Respir Med. 2018;6(2):117–126. doi:10.1016/S2213-2600(18)30006-729331313
  • PascoeS, BarnesN, BrusselleG, et al. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. Lancet Respir Med. 2019;7(9):745–756. doi:10.1016/S2213-2600(19)30190-031281061
  • CalverleyPMA, TetzlaffK, VogelmeierC, et al. Eosinophilia, frequent exacerbations, and steroid response in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196(9):1219–1221. doi:10.1164/rccm.201612-2525LE28306321
  • SiddiquiSH, GuasconiA, VestboJ, et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(4):523–525. doi:10.1164/rccm.201502-0235LE26051430
  • CazzolaM, RoglianiP, CalzettaL, MateraMG. Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis. Eur Respir J. 2018;52(6):1801586. doi:10.1183/13993003.01586-201830309975
  • OshagbemiOA, BurdenAM, BraekenDCW, et al. Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts. Am J Respir Crit Care Med. 2017;195(10):1402–1404. doi:10.1164/rccm.201701-0009LE28165763
  • SpectorSL, TanRA. Is a single blood eosinophil count a reliable marker for “eosinophilic asthma?”. J Asthma. 2012;49(8):807–810. doi:10.3109/02770903.2012.71342822900679
  • SouthworthT, BeechG, FodenP, KolsumU, SinghD. The reproducibility of COPD blood eosinophil counts. Eur Respir J. 2018;52(1):1800427. doi:10.1183/13993003.00427-201829724922
  • LandisSH, SurukiR, HiltonE, ComptonC, GalweyNW. Stability of blood eosinophil count in patients with COPD in the UK clinical practice research datalink. Copd. 2017;14(4):382–388. doi:10.1080/15412555.2017.131382728569614
  • YunJH, LambA, ChaseR, et al. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2018;141(6):2037–2047 e2010. doi:10.1016/j.jaci.2018.04.01029709670
  • LeeJY, ChonGR, RheeCK, et al. Characteristics of patients with chronic obstructive pulmonary disease at the first visit to a pulmonary medical center in Korea: the Korea COPD subgroup study team cohort. J Korean Med Sci. 2016;31(4):553–560. doi:10.3346/jkms.2016.31.4.55327051239
  • R: A Language and Environment for Statistical Computing [Computer Program]. Version 3.4.3. Vienna, Austria: R Foundation for Statistical Computing; 2017.
  • BafadhelM, BarnesN, BourkeS, et al. Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD? Paper presented at: ERS International Congress; 928 - 102, 2019; Madrid, Spain.
  • BelangerM, CouillardS, CourteauJ, et al. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization. Int J Chron Obstruct Pulmon Dis. 2018;13:3045–3054. doi:10.2147/COPD.S17074330319252
  • LiQ, LariveeP, CourteauJ, et al. Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths. Int J Chron Obstruct Pulmon Dis. 2019;14:331–341. doi:10.2147/COPD.S18737530787603
  • KreindlerJL, WatkinsML, LettisS, Tal-SingerR, LocantoreN. Effect of inhaled corticosteroids on blood eosinophil count in steroid-naive patients with COPD. BMJ Open Respir Res. 2016;3(1):e000151. doi:10.1136/bmjresp-2016-000151